2009
DOI: 10.4149/neo_2009_03_208
|View full text |Cite
|
Sign up to set email alerts
|

Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 43 publications
0
7
0
Order By: Relevance
“…Bcl‐2 – another Bcl‐2 gene family protein – represents the founding member of cell death inhibiting oncoproteins. We did not recognize any substantial changes in Bcl‐2 expression in both sensitive A2780 and resistant A2780/CP cells; however, there is a slight increase in basal level of Bcl‐2 in resistant cells observed by our team in the past . Apoptotic stimulation induces cleavage of caspase 9 to p35 or p37 kDa subunits.…”
Section: Resultsmentioning
confidence: 57%
“…Bcl‐2 – another Bcl‐2 gene family protein – represents the founding member of cell death inhibiting oncoproteins. We did not recognize any substantial changes in Bcl‐2 expression in both sensitive A2780 and resistant A2780/CP cells; however, there is a slight increase in basal level of Bcl‐2 in resistant cells observed by our team in the past . Apoptotic stimulation induces cleavage of caspase 9 to p35 or p37 kDa subunits.…”
Section: Resultsmentioning
confidence: 57%
“…Activation of NF-κB contributes to aggressive tumor growth and also to chemotherapy resistance, and, on the other hand, NF-κB inactivation mediates decreased activity of anti-apoptotic-and increased upregulation of apoptotic genes [27,28]. In line with this fact, in recent years much effort has been invested in developing NF-κB-blocking agents, including CDDP, natural compounds and their semisynthetic or synthetic analogues [29][30][31].…”
Section: Discussionmentioning
confidence: 99%
“…This compound provoked activation of ERK 1/2, c-Jun N terminal kinase and p38 signaling pathways [56] in leukemia cell line (HL-60). When this compound was [57].…”
Section: Isothiocyanatesmentioning
confidence: 96%